Literature DB >> 19279011

Involvement of acid beta-glucosidase 1 in the salvage pathway of ceramide formation.

Kazuyuki Kitatani1, Kely Sheldon, Vinodh Rajagopalan, Viviana Anelli, Russell W Jenkins, Ying Sun, Gregory A Grabowski, Lina M Obeid, Yusuf A Hannun.   

Abstract

Activation of protein kinase C (PKC) promotes the salvage pathway of ceramide formation, and acid sphingomyelinase has been implicated, in part, in providing substrate for this pathway (Zeidan, Y. H., and Hannun, Y. A. (2007) J. Biol. Chem. 282, 11549-11561). In the present study, we examined whether acid beta-glucosidase 1 (GBA1), which hydrolyzes glucosylceramide to form lysosomal ceramide, was involved in PKC-regulated formation of ceramide from recycled sphingosine. Glucosylceramide levels declined after treatment of MCF-7 cells with a potent PKC activator, phorbol 12-myristate 13-acetate (PMA). Silencing GBA1 by small interfering RNAs significantly attenuated acid glucocerebrosidase activity and decreased PMA-induced formation of ceramide by 50%. Silencing GBA1 blocked PMA-induced degradation of glucosylceramide and generation of sphingosine, the source for ceramide biosynthesis. Reciprocally, forced expression of GBA1 increased ceramide levels. These observations indicate that GBA1 activation can generate the source (sphingosine) for PMA-induced formation of ceramide through the salvage pathway. Next, the role of PKCdelta, a direct effector of PMA, in the formation of ceramide was determined. By attenuating expression of PKCdelta, cells failed to trigger PMA-induced alterations in levels of ceramide, sphingomyelin, and glucosylceramide. Thus, PKCdelta activation is suggested to stimulate the degradation of both sphingomyelin and glucosylceramide leading to the salvage pathway of ceramide formation. Collectively, GBA1 is identified as a novel source of regulated formation of ceramide, and PKCdelta is an upstream regulator of this pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279011      PMCID: PMC2676029          DOI: 10.1074/jbc.M802790200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  The cell biology of lysosomal storage disorders.

Authors:  Anthony H Futerman; Gerrit van Meer
Journal:  Nat Rev Mol Cell Biol       Date:  2004-07       Impact factor: 94.444

2.  Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells.

Authors:  Makoto Sumitomo; Motoi Ohba; Junichi Asakuma; Takako Asano; Toshio Kuroki; Tomohiko Asano; Masamichi Hayakawa
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Phorbol esters from croton oil. Chemical nature and biological activities.

Authors:  E Hecker
Journal:  Naturwissenschaften       Date:  1967-06

4.  Recycling of glucosylceramide and sphingosine for the biosynthesis of gangliosides and sphingomyelin in rat liver.

Authors:  M Trinchera; R Ghidoni; S Sonnino; G Tettamanti
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

5.  Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs.

Authors:  E H Schuchman; M Suchi; T Takahashi; K Sandhoff; R J Desnick
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

6.  Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipid.

Authors:  Kazuyuki Kitatani; Kely Sheldon; Viviana Anelli; Russell W Jenkins; Ying Sun; Gregory A Grabowski; Lina M Obeid; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

Review 7.  Salvage pathways in glycosphingolipid metabolism.

Authors:  G Tettamanti; R Bassi; P Viani; L Riboni
Journal:  Biochimie       Date:  2003 Mar-Apr       Impact factor: 4.079

8.  Experimental pulmonary inflammatory injury in the monkey.

Authors:  S D Revak; C L Rice; I U Schraufstätter; W A Halsey; B P Bohl; R M Clancy; C G Cochrane
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

9.  Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site.

Authors:  T Dinur; K M Osiecki; G Legler; S Gatt; R J Desnick; G A Grabowski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts.

Authors:  L E Quintern; E H Schuchman; O Levran; M Suchi; K Ferlinz; H Reinke; K Sandhoff; R J Desnick
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  27 in total

1.  Defining a role for acid sphingomyelinase in the p38/interleukin-6 pathway.

Authors:  David M Perry; Benjamin Newcomb; Mohamad Adada; Bill X Wu; Patrick Roddy; Kazuyuki Kitatani; Leah Siskind; Lina M Obeid; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2014-06-20       Impact factor: 5.157

Review 2.  The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease.

Authors:  Lena F Burbulla; Dimitri Krainc
Journal:  Neurobiol Dis       Date:  2019-07-25       Impact factor: 5.996

Review 3.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

4.  Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function.

Authors:  Myung Jong Kim; Sohee Jeon; Lena F Burbulla; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2018-06-01       Impact factor: 6.150

Review 5.  Ceramides as modulators of cellular and whole-body metabolism.

Authors:  Benjamin T Bikman; Scott A Summers
Journal:  J Clin Invest       Date:  2011-11-01       Impact factor: 14.808

6.  Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase.

Authors:  Russell W Jenkins; Christopher J Clarke; Daniel Canals; Ashley J Snider; Christopher R Gault; Linda Heffernan-Stroud; Bill X Wu; Fabio Simbari; Patrick Roddy; Kazuyuki Kitatani; Lina M Obeid; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2011-02-18       Impact factor: 5.157

7.  Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation.

Authors:  Russell W Jenkins; Daniel Canals; Jolanta Idkowiak-Baldys; Fabio Simbari; Patrick Roddy; David M Perry; Kazuyuki Kitatani; Chiara Luberto; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

8.  Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.

Authors:  Russell P Bowler; Sean Jacobson; Charmion Cruickshank; Grant J Hughes; Charlotte Siska; Daniel S Ory; Irina Petrache; Jean E Schaffer; Nichole Reisdorph; Katerina Kechris
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

9.  Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipid.

Authors:  Kazuyuki Kitatani; Kely Sheldon; Viviana Anelli; Russell W Jenkins; Ying Sun; Gregory A Grabowski; Lina M Obeid; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

Review 10.  Gaucher's disease and cancer: a sphingolipid perspective.

Authors:  Brian M Barth; Sriram S Shanmugavelandy; Diana M Tacelosky; Mark Kester; Samy A F Morad; Myles C Cabot
Journal:  Crit Rev Oncog       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.